Adlumiz

anamorelin hydrochloride · Helsinn Birex Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adlumiz, covering 2017-11-30 to 2017-11-30. Get the full timeline:

Most recent: EMA Refused: Adlumiz (anamorelin hydrochloride) — Helsinn Birex Pharmaceuticals Ltd.